Acadia Healthcare Company (ACHC) Cost of Revenue (2010 - 2026)

Acadia Healthcare Company (ACHC) has reported Cost of Revenue for 17 consecutive years, with $155.7 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Cost of Revenue rose 15.87% year-over-year to $155.7 million; the TTM figure through Jun 2026 stood at $591.7 million (up 23.68% YoY), while the FY2025 annual figure was $553.3 million, up 25.53% from the prior year.
• Cost of Revenue rose to $155.7 million in Q2 2026 per ACHC's latest filing, from $131.1 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $176.1 million in Q4 2025 and bottomed at $81.4 million in Q1 2022.
• Historically, Cost of Revenue has averaged $112.2 million across 5 years, with a median of $106.9 million in 2023.
• Annual changes were most pronounced in 2023 — Cost of Revenue advanced 4.46% — and 2025, when it surged 49.38%.
• Acadia Healthcare Company's Cost of Revenue stood at $93.9 million in 2022, then grew by 4.46% to $98.1 million in 2023, then increased by 20.16% to $117.9 million in 2024, then soared by 49.38% to $176.1 million in 2025, then retreated by 11.56% to $155.7 million in 2026.
• Business Quant data shows ACHC's Cost of Revenue at $155.7 million in Q2 2026, $131.1 million in Q1 2026, and $176.1 million in Q4 2025.